Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein

Biochemical Pharmacology
M B Anand-Srivastava

Abstract

The effect of angiotensin II (AII) on adenylate cyclase was studied in the rat and rabbit heart sarcolemma. AII inhibited adenylate cyclase activity in the rat and rabbit sarcolemma in a concentration-dependent manner. Maximal inhibition of about 35-40% was observed in the rat, with an apparent Ki of about 3 nM; about 30% inhibition, with an apparent Ki of about 6 nM, was noted in rabbit sarcolemma. The inhibitory effect of AII was dependent on the presence of guanine nucleotides and was blocked by saralasin. In addition, AII also inhibited the stimulatory effects of isoproterenol and glucagon on adenylate cyclase. Ninhibin, a sperm factor which has been shown to modify the characteristics of inhibitory guanine nucleotide regulatory protein (Gi), attenuated the inhibitory effects of AII on basal and hormone-sensitive adenylate cyclase. Furthermore, pertussis toxin (PT) treatment of the sarcolemma in the presence of [32P]NAD resulted in ADP-ribosylation of a single 41-kD protein. PT also attenuated the AII-mediated inhibition of basal and hormone-sensitive adenylate cyclase and enhanced the magnitude of the stimulatory effects of isoproterenol and glucagon on adenylate cyclase activity. These data suggest that the rat myocardial...Continue Reading

References

Jan 1, 1978·Biochemical Pharmacology·M A Devynck, P Meyer
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Cassel, T Pfeuffer
Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D M Gill, R Meren
Jul 1, 1978·European Journal of Pharmacology·M KobayashiS Chiba
Oct 1, 1976·The Journal of Clinical Investigation·J Douglas, K J Catt
Dec 1, 1985·Archives of Biochemistry and Biophysics·M B Anand-Srivastava
Mar 1, 1985·The American Journal of Physiology·J R WilliamsonA P Thomas
Apr 30, 1985·Biochemical and Biophysical Research Communications·C C MalbonD C Watkins
Feb 5, 1971·Biochemical and Biophysical Research Communications·M BaudouinM Worcel
Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
Jan 1, 1984·The Journal of Clinical Investigation·A G Gilman
Mar 30, 1982·Biochemical and Biophysical Research Communications·A MukherjeeJ L Sutko
Sep 1, 1982·Circulation Research·T J Moore, G H Williams
Dec 16, 1983·Biochemical and Biophysical Research Communications·M B Anand-Srivastava
Oct 1, 1983·Biochemical Pharmacology·M B Anand-SrivastavaJ Genest
Apr 20, 1983·Biochimica Et Biophysica Acta·K H JakobsG Schultz
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T Katada, M Ui
Nov 1, 1982·Endocrinology·E A Woodcock, C I Johnston

❮ Previous
Next ❯

Citations

Aug 8, 1991·Biochemical Pharmacology·P S Sunga, S W Rabkin
Dec 15, 2005·Heart, Lung & Circulation·M G Vila Petroff, A R Mattiazzi
Nov 30, 1990·Biochemical and Biophysical Research Communications·H RoggM de Gasparo
Apr 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Yakhin Shimoni, Xiu-Fang Liu
Dec 1, 1992·Circulation Research·L A SechiM Schambelan
Mar 1, 1996·Hypertension·H Gomez LlambiC M Taquini
Apr 29, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Yuan LiMadhu B Anand-Srivastava
Sep 21, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Yuan LiMadhu B Anand-Srivastava
Jul 31, 1998·The American Journal of Physiology·J R HenegarJ S Janicki
Dec 13, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Yuan LiMadhu B Anand-Srivastava
Apr 25, 2003·Canadian Journal of Physiology and Pharmacology·Madhu B Anand-Srivastava, Anuradha Palaparti
Aug 26, 1998·Medizinische Klinik·C UnterbergA B Buchwald
Oct 23, 2020·Canadian Journal of Physiology and Pharmacology·Vanessa TruongAshok K Srivastava
May 1, 1999·Archives of Biochemistry and Biophysics·A PalapartiM B Anand-Srivastava
May 17, 2003·Archives of Oral Biology·Minako AbeTakashi Suzuki
Jul 17, 2021·American Journal of Physiology. Heart and Circulatory Physiology·Ekhtear HossainMadhu B Anand-Srivastava

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.